rs374404353
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM1BP4_StrongBP6BS2
The NM_005101.4(ISG15):c.296G>A(p.Arg99Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000985 in 1,613,436 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005101.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ISG15 | NM_005101.4 | c.296G>A | p.Arg99Gln | missense_variant | 2/2 | ENST00000649529.1 | NP_005092.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ISG15 | ENST00000649529.1 | c.296G>A | p.Arg99Gln | missense_variant | 2/2 | NM_005101.4 | ENSP00000496832 | P1 | ||
ISG15 | ENST00000624697.4 | c.272G>A | p.Arg91Gln | missense_variant | 3/3 | 3 | ENSP00000485643 | |||
ISG15 | ENST00000624652.1 | c.272G>A | p.Arg91Gln | missense_variant | 3/3 | 3 | ENSP00000485313 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152234Hom.: 2 Cov.: 34
GnomAD3 exomes AF: 0.0000599 AC: 15AN: 250368Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135646
GnomAD4 exome AF: 0.0000862 AC: 126AN: 1461202Hom.: 2 Cov.: 38 AF XY: 0.0000825 AC XY: 60AN XY: 726914
GnomAD4 genome AF: 0.000217 AC: 33AN: 152234Hom.: 2 Cov.: 34 AF XY: 0.0000672 AC XY: 5AN XY: 74380
ClinVar
Submissions by phenotype
Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Apr 22, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Mar 30, 2021 | ISG15 NM_005101.3 exon 2 p.Arg99Gln (c.296G>A): This variant has not been reported in the literature but is present in 0.06% (12/19930) of East Asian alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/1-949656-G-A?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:568195). This variant amino acid Glutamine (Gln) is present in >20 species including mammals and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 03, 2024 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 25, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at